Incremental value and safety of oral ivabradine for heart rate reduction in computed tomography coronary angiography.

Massimo Midiri, Riccardo Ieva, Andrea I. Guaricci, Erica Maffei, Carlo Tedeschi, Luigi Di Biase, Deodata Montrone, Joanne D. Schuijf, Matteo Di Biase, Luca Macarini, Filippo Cademartiri, Massimo Midiri, Natale Daniele Brunetti

Risultato della ricerca: Articlepeer review

48 Citazioni (Scopus)


Background: Heart rate (HR) reduction is essential to achieve optimal image quality and diagnostic accuracy with computed tomography coronary angiography (CTCA). Administration of ivabradine could be an attractive alternative to beta-blockade to reduce HR.Methods: One-hundred-twenty-three patients referred for CTCA were prospectively enrolled. Patients were divided in two groups depending on the absence or presence of chronic beta-blockade treatment. Within the two groups patients were randomized to either no additional premedication or oral ivabradine for 5 days prior to CTCA. In presence of chronic beta-blockade therapy it was shifted to atenolol 50 mg twice a day for 5 days prior to CTCA. HR and blood pressure were assessed at admission (T0), immediately before CTCA (T1) and during CTCA (T2). The target HR was <65 bpm.Results: Ivabradine significantly reduced HR during CTCA. Mean relative HR reduction was 15% for controls, 12% for chronic beta-blockade, 19% for ivabradine and 24% for both chronic beta-blockade and ivabradine at T2 (p for trend <0.001). The rate of patients who reached the target HR at T2 was 83% in controls, 71% with chronic beta-blockade, 97% with ivabradine and 97% with both (p for trend <0.05). The percentage of patients that needed additional IV beta-blockade at T1 decreased from 69% to 40% with ivabradine and 30% with both (p for trend <0.05).Conclusions: Ivabradine is safe and effective in increasing the rate of patients at target HR and in reducing the need for additional IV beta-blockade in patients referred for CTCA.
Lingua originaleEnglish
pagine (da-a)28-33
Numero di pagine6
Stato di pubblicazionePublished - 2012

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.2700.2705???


Entra nei temi di ricerca di 'Incremental value and safety of oral ivabradine for heart rate reduction in computed tomography coronary angiography.'. Insieme formano una fingerprint unica.

Cita questo